Biotech bet pays big in Merck exit

Lebanon, New Hampshire-based GlycoFi will be acquired by Merck in an exit coup for the biotech company’s venture backers.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this